{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:38:08Z","timestamp":1794541088402,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":27,"publisher":"Springer New York","isbn-type":[{"value":"9781493968152","type":"print"},{"value":"9781493968176","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-6817-6_19","type":"book-chapter","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T13:11:33Z","timestamp":1490965893000},"page":"229-239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intracerebroventricular Delivery in Mice for Motor Neuron Diseases"],"prefix":"10.1007","author":[{"given":"M.","family":"Nizzardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rizzuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,1]]},"reference":[{"key":"19_CR1","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/WCO.0b013e328356d328","volume":"25","author":"AC Ludolph","year":"2012","unstructured":"Ludolph AC, Brettschneider J, Weishaupt JH (2012) Amyotrophic lateral sclerosis. Curr Opin Neurol 25:530\u2013535","journal-title":"Curr Opin Neurol"},{"key":"19_CR2","first-page":"6","volume":"2","author":"A D'Amico","year":"2011","unstructured":"D'Amico A, Mercuri E, Tiziano FD, Bertini E (2011) Spinal muscular atrophy. Orphanet J Rare Dis 2:6\u201371","journal-title":"Orphanet J Rare Dis"},{"key":"19_CR3","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","volume":"82","author":"Y Hua","year":"2008","unstructured":"Hua Y, Vickers TA, Okunola HL, Bennett CF, Krainer AR (2008) Antisense masking of an hnRNPA1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. Am J Hum Genet 82:834\u2013848","journal-title":"Am J Hum Genet"},{"issue":"72","key":"19_CR4","doi-asserted-by":"publisher","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","volume":"3","author":"MA Passini","year":"2011","unstructured":"Passini MA, Bu J, Richards AM, Kinnecom C, Sardi SP, Stanek LM, Hua Y, Rigo F, Matson J, Hung G, Kaye EM, Shihabuddin LS, Krainer AR, Bennett CF, Cheng SH (2011) Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy. Sci Transl Med 3(72):72ra18","journal-title":"Sci Transl Med"},{"issue":"3","key":"19_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.clinthera.2014.02.004","volume":"36","author":"M Nizzardo","year":"2014","unstructured":"Nizzardo M, Simone C, Salani S, Ruepp MD, Rizzo F, Ruggieri M, Zanetta C, Brajkovic S, Moulton HM, M\u00fcehlemann O, Bresolin N, Comi GP, Corti S (2014) Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy \u03947 mouse model phenotype. Clin Ther 36(3):340\u2013356","journal-title":"Clin Ther"},{"key":"19_CR6","doi-asserted-by":"publisher","first-page":"21301","DOI":"10.1038\/srep21301","volume":"6","author":"M Nizzardo","year":"2016","unstructured":"Nizzardo M, Simone C, Rizzo F, Ulzi G, Ramirez A, Rizzuti M, Bordoni A, Bucchia M, Gatti S, Bresolin N, Comi GP, Corti S (2016) Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype. Sci Rep 6:21301","journal-title":"Sci Rep"},{"key":"19_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1006\/geno.1996.0147","volume":"32","author":"L Burglen","year":"1996","unstructured":"Burglen L, Lefebvre S, Clermont O, Burlet P, Viollet L, Cruaud C, Munnich A, Melki J (1996) Structure and organization of the human survival motor neuron (SMN) gene. Genomics 32:479\u2013482","journal-title":"Genomics"},{"key":"19_CR8","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","volume":"8","author":"UR Monani","year":"1999","unstructured":"Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, McPherson JD (1999) A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 8:1177\u20131183","journal-title":"Hum Mol Genet"},{"key":"19_CR9","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.2353\/ajpath.2007.070399","volume":"171","author":"J Vitte","year":"2007","unstructured":"Vitte J, Fassier C, Tiziano FD, Dalard C, Soave S, Roblot N, Brahe C, Saugier-Veber P, Bonnefont JP, Melki J (2007) Refined characterization of the expression and stability of the SMN gene products. Am J Pathol 171:1269\u20131280","journal-title":"Am J Pathol"},{"key":"19_CR10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nn.2565","volume":"7","author":"M Sendtner","year":"2010","unstructured":"Sendtner M (2010) Therapy development in spinal muscular atrophy. Nat Neurosci 7:795\u2013799","journal-title":"Nat Neurosci"},{"issue":"4","key":"19_CR11","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1128\/MCB.26.4.1333-1346.2006","volume":"26","author":"NK Singh","year":"2006","unstructured":"Singh NK, Singh NN, Androphy EJ, Singh RN (2006) Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron. Mol Cell Biol 26(4):1333\u20131346","journal-title":"Mol Cell Biol"},{"issue":"4","key":"19_CR12","doi-asserted-by":"publisher","first-page":"e62114","DOI":"10.1371\/journal.pone.0062114","volume":"8","author":"C Mitrpant","year":"2013","unstructured":"Mitrpant C, Porensky P, Zhou H, Price L, Muntoni F, Fletcher S, Wilton SD, Burghes AHM (2013) Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy. PLoS One 8(4):e62114","journal-title":"PLoS One"},{"issue":"3","key":"19_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1089\/hum.2012.211","volume":"24","author":"H Zhou","year":"2013","unstructured":"Zhou H, Janghra N, Mitrpant C, Dickinson R, Anthony K, Price L, Eperon I, Wilton S, Morgan J, Muntoni F (2013) A novel morpholino oligomer targeting ISSN1 improves rescue of severe SMA transgenic mice. Hum Gene Ther 24(3):331\u2013342","journal-title":"Hum Gene Ther"},{"key":"19_CR14","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","volume":"21","author":"PN Porensky","year":"2012","unstructured":"Porensky PN, Mitrpant C, McGovern VL, Bevan AK, Foust KD, Kaspar BK, Wilton SD, Burghes AHM (2012) A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Hum Mol Genet 21:1625\u20131638","journal-title":"Hum Mol Genet"},{"issue":"22","key":"19_CR15","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1093\/hmg\/ddv329","volume":"24","author":"H Zhou","year":"2015","unstructured":"Zhou H, Meng J, Marrosu E, Janghra N, Morgan J, Muntoni F (2015) Repeated low doses of morpholino antisense oligomer: an intermediate mouse model of spinal muscular atrophy to explore the window of therapeutic response. Hum Mol Genet 24(22):6265\u20136277","journal-title":"Hum Mol Genet"},{"issue":"1","key":"19_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nn.3584","volume":"17","author":"AE Renton","year":"2014","unstructured":"Renton AE, Chio A, Traynor BJ (2014) State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 17(1):17\u201323","journal-title":"Nat Neurosci"},{"issue":"6415","key":"19_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX (1993) Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362(6415):59\u201362","journal-title":"Nature"},{"key":"19_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3389\/fncel.2013.00253","volume":"7","author":"MS Rotunno","year":"2013","unstructured":"Rotunno MS, Bosco DA (2013) An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. Front Cell Neurosci 7:253","journal-title":"Front Cell Neurosci"},{"key":"19_CR19","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1126\/science.281.5384.1851","volume":"281","author":"LI Bruijn","year":"1998","unstructured":"Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, Ohama E, Reaume AG, Scott RW, Cleveland DW (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281:1851\u20131854","journal-title":"Science"},{"key":"19_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1471-4159.2007.04531.x","volume":"102","author":"SA Ezzi","year":"2007","unstructured":"Ezzi SA, Urushitani M, Julien JP (2007) Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J Neurochem 102:170\u2013178","journal-title":"J Neurochem"},{"key":"19_CR21","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1038\/nn.2660","volume":"13","author":"DA Bosco","year":"2010","unstructured":"Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, Pasinelli P, Goolsby H, Fontaine BA, Lemay N, McKenna-Yasek D, Frosch MP, Agar JN, Julien JP, Brady ST, Brown RH Jr (2010) Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci 13:1396\u20131403","journal-title":"Nat Neurosci"},{"issue":"13","key":"19_CR22","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1073\/pnas.1115402109","volume":"109","author":"S Guareschi","year":"2012","unstructured":"Guareschi S, Cova E, Cereda C, Ceroni M, Donetti E, Bosco DA, Trotti D, Pasinelli P (2012) An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc Natl Acad Sci U S A 109(13):5074\u20135079","journal-title":"Proc Natl Acad Sci U S A"},{"key":"19_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm1205","volume":"11","author":"GS Ralph","year":"2005","unstructured":"Ralph GS, Radcliffe PA, Day DM, Carthy JM, Leroux MA, Lee DC, Wong LF, Bilsland LG, Greensmith L, Kingsman SM, Mitrophanous KA, Mazarakis ND, Azzouz M (2005) Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat Med 11:429\u2013433","journal-title":"Nat Med"},{"key":"19_CR24","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1172\/JCI25424","volume":"116","author":"RA Smith","year":"2006","unstructured":"Smith RA, Miller TM, Yamanaka K, Monia BP, Condon TP, Hung G, Lobsiger CS, Ward CM, McAlonis-Downes M, Wei H, Wancewicz EV, Bennett CF, Cleveland DW (2006) Antisense oligonucleotide therapy for neurodegenerative disease. J Clin Invest 116:2290\u20132296","journal-title":"J Clin Invest"},{"key":"19_CR25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/hmg\/ddi078","volume":"14","author":"TT Le","year":"2005","unstructured":"Le TT, Pham LT, Butchbach ME, Zhang HL (2005) SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet 14:845\u2013857","journal-title":"Hum Mol Genet"},{"key":"19_CR26","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.8209258","volume":"264","author":"ME Gurney","year":"1994","unstructured":"Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX et al (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264:1772\u20131775","journal-title":"Science"},{"issue":"1","key":"19_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1124\/jpet.113.212407","volume":"350","author":"F Rigo","year":"2014","unstructured":"Rigo F, Chun SJ, Norris DA, Hung G, Lee S, Matson J, Fey RA, Gaus H, Hua Y, Grundy JS, Krainer AR, Henry SP, Bennett CF (2014) Pharmacology of a central nervous system delivered 2\u2032-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates. J Pharmacol Exp Ther 350(1):46\u201355","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Methods in Molecular Biology","Morpholino Oligomers"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-6817-6_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T01:55:34Z","timestamp":1558058134000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-6817-6_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9781493968152","9781493968176"],"references-count":27,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-6817-6_19","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-6817-6","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"1 April 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}